vs
Side-by-side financial comparison of Regencell Bioscience Holdings Ltd (RGC) and SNDL Inc. (SNDL). Click either name above to swap in a different company.
Regencell Bioscience Holdings Ltd is a specialized bioscience enterprise focused on the research, development and commercialization of therapeutic products derived from traditional Chinese medicine. Its core pipeline targets neurodegenerative, immunological and infectious disease treatments, with primary operating markets across Greater China and other Asian regions.
SNDL Inc. is a Canada-based consumer goods company focused primarily on the cannabis sector, offering a range of recreational and medical cannabis products, alongside craft beer, wine and spirit offerings. It operates across cultivation, product development, distribution and retail segments, serving both wholesale and retail customers mainly in the North American market.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 25 | — | $77.5M | ||
| Q1 24 | — | $116.1M | ||
| Q1 23 | — | $115.9M |
| Q1 25 | — | 25.3% | ||
| Q1 24 | — | 24.8% | ||
| Q1 23 | — | — |
| Q1 25 | — | 6.7% | ||
| Q1 24 | — | 1.9% | ||
| Q1 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
